PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994–1998

@article{Nelson2001PBSRPBSCI,
  title={PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994–1998},
  author={Mark R Nelson and John J. McNeil and Anna Peeters and Christopher M. Reid and Henry Krum},
  journal={Medical Journal of Australia},
  year={2001},
  volume={174}
}
To determine the extent to which “current guidelines” for the management of hypertension are reflected in the prescribing of antihypertensive drugs in Australia over the period 1994–1998, and to examine the cost implications of actual and recommended prescribing patterns. 
PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension
TLDR
Current prescribing patterns indicate that clinical practice has pre-empted the results from clinical trials of newer, more expensive agents and that clinicians' prescribing patterns do not closely reflect current recommendations. Expand
PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension
group status (MRSA or MSSA) failed to achieve significance in any iteration of the regression, while LOS remained a significant predictor of mortality risk. This suggests that, with S. aureusExpand
Cost analysis of ambulatory blood pressure monitoring in initiating antihypertensive drug treatment in Australian general practice
TLDR
The cost of ambulatory blood pressure monitoring (ABPM) with the putative savings made through treatment avoided by identification and non‐treatment of those with “white coat” hypertension are compared. Expand
The Need for Evidence in Hypertension Management: Historical Perspective
TLDR
The concept of “the lower the blood pressure the better without causing symptoms” was the rule until the J-curve hypothesis emerged and generated a long debate, now the current evidence supports the old concept, at least for some conditions such as hypertension in diabetic patients or in those with nephrotic-range proteinuria. Expand
Budget impact analysis of the adoption of new hypertension guidelines in Colombia
TLDR
A high-middle income country such as Colombia should carry out an exhaustive revision of the recommendations of the new hypertension guideline, due to its high probability of saving medical treatment costs for the healthcare system. Expand
Drug treatment and cost of cardiovascular disease in Australia.
TLDR
The present study suggests that there is scope to improve the treatment of high-risk participants in Australia, as participants with existing cerebrovascular disease and peripheral vascular disease receive less preventive therapy than those with CAD or even risk factors alone. Expand
Factors Influencing Family Physician Adherence to Hypertension Treatment Guideline Recommendations on the Initiation of Pharmacotherapy
TLDR
There is a demonstrable need for governments to invest in the promotion of accurate information on drugs through continuing education of prescribers and facilitating the production of standardized paper and web-based clinical guidelines. Expand
Public funding of large‐scale clinical trials in Australia
Failure to provide public funding for clinical trials may come at a high cost to the community in the long term.
MEDicine or MADness
  • D. Currow
  • Sociology, Medicine
  • The Medical journal of Australia
  • 2002
TLDR
The contribution made by the authors in developing a technique to estimate appropriate use for hypertension drugs is valuable, but use of unreferenced estimates of key variables, insufficient application of sensitivity analyses, algebraic errors and inappropriately combining PBS with non-PBS data may cloud rather than shed light on this issue. Expand
MEDicine or MADness
three main concerns we have with the paper’s estimates are as follows: ■ The total number of patients on monotherapy in Box 3 of the article adds to 1.1 million, whereas elsewhere the authors stateExpand
...
1
2
...

References

SHOWING 1-3 OF 3 REFERENCES
R'ylll" p. 'It aj Secontl AUSI.""". NatO)"dl B1QO(1 Press....e Sluo.,. (AN8P2) A..sIr" I.
  • P\'Il'$'O'
  • 1997
NaIOOf\llI BkJcxj l'1" s
    an tlhrPB' lens,,e Ot..<gs [ 1 セ "eBIITIf!>'l( 01 ""ilh bIoocI Dles SU'<! Tile SI01h 'eDO
    • \ 01hoghblood pl"$ !I'.Illl (JNC VI